Industry news

New studies show that devices, not just drugs, can help treat strokes

Varun Saxena / FierceMedicalDevices

Groundbreaking studies that resulted in standing ovations at the International Stroke Conference in Nashville, TN, offered more evidence that revascularization devices that physically remove blood clots from the brain are a valuable and potentially lifesaving addition to pharmaceutical therapy in stroke patients.

Report: 'Carrot and stick' needed to deal with drug shortages

Eric Palmer, FeircePharmaManufactoring

Shortages of essential, often lifesaving, drugs continue to plague countries globally, and they are looking at different ways to combat them. Canada will now require drugmakers to report shortages, a practice that has been voluntary. 

Investors set sail toward China's rapidly growing device market

Emily Wasserman, FierceMedicalDevices

Amid rapid growth in China's medical device sector, investors are looking to cash in on the market with a string of M&A deals.

12 February 2015

Eyeing $14B epilepsy market, biopharma firm moves to Philly suburb

John George / Philadelphia Business Journal

The story of Marinus Pharmaceuticals, a biophamraceutical company developing new treatments for epilepsy and other neuropsychiatric disorders. The market for epilepsy treatments is estimated at more than $14 billion. Marinus is initially targeting a $4 billion subset of that market: patients with seizures who don't respond or are no longer responding to other medications in the market.

Game-changer: A new plan takes shape to spur the U.K.'s biotech cluster

John Carroll, FierceBiotech

he common wisdom about the U.K.'s life sciences industry has been set in stone for years now. Great drug science is ingrained in the country's stellar academic centers, building on decades of outstanding lab work. But the biotech industry has never achieved the kind of success that the science would seemingly portend, unable to spawn the development of a key cluster like Cambridge/Boston and the sprawling San Francisco Bay Area life sciences hub.

Will Economic Returns from Drugs Continue to Disintegrate?

Randi Hernandez / BioPharm International

5 Reasons Why Telemedicine Is the Health Care Industry's Underdog

Frieda Wiley / Pharmacy Times

The word “telemedicine” may seem as paradoxical in name as it is in practice. At no other time in the history of medicine have we ever seen such a documented expansion in the variety of services that empower health care professionals with more opportunities to optimize patient care than we have in the last 20 years. Still, the practice of medicine—in any regard—normally involves a direct encounter between a patient and health care professional, so providing historically tangible services in real time to intangible patients is beyond ironic.

Russian medical companies enter Syrian and Indian markets

MarchMont Innovation News

Russia may soon start exporting medical products to Syria and India. Russian manufacturers signed a number of agreements at the most recent international Arab Health 2015 exhibition in the UAE, the largest show of medical production innovation in the Middle East and the second largest globally,  announced  the website of the Russian Ministry of Industry and Commerce. 

Russians and Americans develop early-stage cancer diagnostics in Siberia

MarchMont Innovation News

Researchers at the Russia-US Anti-Cancer Center in Barnaul, in Southwest Siberia, a joint project launched more than a year ago on the premises of Altay State University, say it will take them three years to complete the testing of a technology which is believed to enable physicians to rapidly diagnose cancers at very early stages, using literally just one drop of a patient’s blood. 

Why crowdfunding will never be a big factor in biotech

John Carroll, FierceBiotech

Against the backdrop of a surge in venture investing in biotech, there's been a significant amount of curiosity in the startup field about whether crowdfunding can ever play a significant role in seeding new operations.